MANF Is Neuroprotective in Early Stages of EAE, and Elevated in Spinal White Matter by Treatment With Dexamethasone

by Jinhan Nam, Tapani K. Koppinen, Merja H. Voutilainen
Published 2021-07-01

AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models

by Katrina Albert, Merja H. Voutilainen, Andrii Domanskyi, Mikko Airavaara
Published 2017-02-01

Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra

by Katrina Albert, Juho-Matti Renko, Kert Mätlik, Mikko Airavaara, Mikko Airavaara, Merja H. Voutilainen
Published 2019-06-01

CDNF Protects the Nigrostriatal Dopamine System and Promotes Recovery after MPTP Treatment in Mice

by Mikko Airavaara, Brandon K. Harvey, Merja H. Voutilainen, Hui Shen, Jenny Chou, Päivi Lindholm, Maria Lindahl, Raimo K. Tuominen, Mart Saarma, Barry Hoffer, Yun Wang
Published 2012-06-01

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease

by Anna-Maija Penttinen, Ilmari Parkkinen, Merja H. Voutilainen, Maryna Koskela, Susanne Bäck, Anna Their, Christopher T. Richie, Andrii Domanskyi, Brandon K. Harvey, Raimo K. Tuominen, Liina Nevalaita, Mart Saarma, Mikko Airavaara
Published 2018-06-01